Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Obes Relat Metab Disord ; 27(12): 1486-93, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14634679

RESUMEN

OBJECTIVE: To evaluate the effectiveness of a culturally appropriate lifestyle intervention combined with orlistat in producing weight loss with obese Mexican-American women. SUBJECTS: Mexican-American women (N=108), aged 21-65 y, with a body mass index (BMI) > or =27 kg/m(2) were randomized to 1 y of treatment with orlistat and a culturally tailored lifestyle modification intervention (OLM; n=56) or a wait-list control group (WLC; n=52). DESIGN: A randomized, controlled, open-label 12-month study. Orlistat was dosed at 120 mg, three times per day. The OLM intervention included behavior modification, a low-fat (< or =30% of total daily calories) diet, and moderate physical activity (> or =150 min/week). MEASUREMENT: Primary outcomes included changes in body weight (kg), BMI, waist circumference, blood pressure, glucose, and lipids. RESULTS: A total of 72 (37 OLM, 35 WLC) and 66 participants (32 OLM, 34 WLC) completed the 6- and 12-month follow-ups, respectively. Repeated-measures ANOVA demonstrated a significant time x treatment interaction (Wilks' lambda=12.61; P<0.001), indicating that OLM-treated patients achieved significant weight loss relative to the WLC group during the study (mean percentage weight loss+/-s.e.m.; -8.1%+/-1.2 vs -1.6%+/-0.7 at 6 months and -8.8%+/-1.5 vs -0.2%+/-1.0 at 12 months, respectively). OLM-treated patients also experienced significant reductions in waist circumference, low-density-lipoprotein, and total cholesterol. CONCLUSIONS: This study demonstrates the effectiveness of an intervention combining orlistat and lifestyle modification with Mexican-American women, a population with substantial risk for obesity.


Asunto(s)
Fármacos Antiobesidad/uso terapéutico , Terapia Conductista , Lactonas/uso terapéutico , Obesidad/terapia , Pérdida de Peso , Adulto , Anciano , Fármacos Antiobesidad/efectos adversos , Enfermedades Cardiovasculares/etiología , Terapia Combinada , Inhibidores Enzimáticos/efectos adversos , Inhibidores Enzimáticos/uso terapéutico , Femenino , Estudios de Seguimiento , Humanos , Lactonas/efectos adversos , Estilo de Vida , Lipasa/antagonistas & inhibidores , Americanos Mexicanos , Persona de Mediana Edad , Obesidad/dietoterapia , Obesidad/etnología , Orlistat , Factores de Riesgo , Resultado del Tratamiento , Negativa del Paciente al Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA